{"url_path":"/sec/bkyi/8-k/2026-03-31/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **         **Financial Statements, Pro Forma Financial Information and Exhibit.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-31","source_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-010506-index.html","accession_number":"0001437749-26-010506","cik":"0001019034","ticker":"BKYI","issuer_name":"BIO KEY INTERNATIONAL INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-010506-index.html","primary_entity_key":"0001019034","primary_entity_name":"BIO KEY INTERNATIONAL INC"},"word_count":106,"has_tables":true,"body_markdown":"**Item 9.01.**         **Financial Statements, Pro Forma Financial Information and Exhibit.**\n\n \n\n(d)\n\nExhibits. The following exhibit is furnished herewith:\n\n \n\n99.1\n\n[Press Release, dated March 31, 2026, issued by the Company.](ex_939585.htm)\n\n \n\n104\n\nCover Page Interactive Data File (embedded with the Inline XBRL document)\n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nBIO-KEY INTERNATIONAL, INC.\n\n \n\nDate: March 31,2026\n\n \n \n \n\n \n \n \n \n\n \n\nBy:\n\n/s/ Cecilia C. Welch\n\n \n\n \n \n\nCecilia C. Welch\n\n \n\n \n \n\nChief Financial Officer\n\n \n\n \n\n \n\n \n\n \n\n**EXHIBIT INDEX**\n\n \n\n \n\n**Exhibit No.**\n\n**Description**\n\n \n \n\n99.1\n\nPress Release, dated March 31, 2026 issued by the Company."}